Liang Dai

1.4k total citations
49 papers, 1.1k citations indexed

About

Liang Dai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Liang Dai has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Liang Dai's work include Liver Disease Diagnosis and Treatment (6 papers), interferon and immune responses (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Liang Dai is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), interferon and immune responses (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Liang Dai collaborates with scholars based in China, Singapore and Ethiopia. Liang Dai's co-authors include Peter Cheung, Xinyu Liu, Chan Aye Thu, Xiaoan Wen, Haoliang Yuan, Hongbin Sun, Wanpu Yan, Xiaozheng Kang, Caiping Chen and Luyan Shen and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Biochemical Journal.

In The Last Decade

Liang Dai

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liang Dai China 19 627 292 246 175 117 49 1.1k
Qianqian Yin China 20 1.0k 1.6× 209 0.7× 121 0.5× 201 1.1× 91 0.8× 63 1.4k
Mohammad Sarwar Jamal Saudi Arabia 19 467 0.7× 136 0.5× 130 0.5× 203 1.2× 82 0.7× 37 992
Zhu Yuan China 24 1.0k 1.6× 274 0.9× 180 0.7× 394 2.3× 50 0.4× 68 1.4k
Yanli Jin China 23 1.1k 1.7× 179 0.6× 146 0.6× 289 1.7× 63 0.5× 45 1.5k
Xiaohui Hu China 21 705 1.1× 417 1.4× 307 1.2× 111 0.6× 69 0.6× 64 1.4k
Wenhua Lu China 22 727 1.2× 412 1.4× 280 1.1× 283 1.6× 38 0.3× 65 1.4k
Clarissa Araújo Gurgel Rocha Brazil 22 491 0.8× 133 0.5× 110 0.4× 233 1.3× 135 1.2× 72 1.1k
Chunlai Nie China 22 796 1.3× 169 0.6× 138 0.6× 293 1.7× 53 0.5× 57 1.3k
Jie Jiang China 19 670 1.1× 452 1.5× 113 0.5× 190 1.1× 58 0.5× 58 1.2k

Countries citing papers authored by Liang Dai

Since Specialization
Citations

This map shows the geographic impact of Liang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Dai more than expected).

Fields of papers citing papers by Liang Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Dai. The network helps show where Liang Dai may publish in the future.

Co-authorship network of co-authors of Liang Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Liang Dai. A scholar is included among the top collaborators of Liang Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Dai. Liang Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Min, et al.. (2025). Design, synthesis, and Biological evaluation of novel macrocyclic derivatives as potent ATP-citrate lyase inhibitors. European Journal of Medicinal Chemistry. 292. 117684–117684. 1 indexed citations
2.
Ma, Guangcai, Haohao Liu, Jiaxin Li, et al.. (2025). Discovery of an Orally Bioavailable STING Inhibitor with In Vivo Anti-Inflammatory Activity in Mice with STING-Mediated Inflammation. Journal of Medicinal Chemistry. 68(3). 2963–2980. 8 indexed citations
3.
4.
Wang, Yanyan, Xing Zhao, Fengqin Wang, et al.. (2024). Design, synthesis, and biological evaluation of piperazine derivatives as pan-PPARs agonists for the treatment of liver fibrosis. European Journal of Medicinal Chemistry. 269. 116344–116344. 2 indexed citations
5.
Zhang, Xuwu, Xinyue Zhang, Shiqi Liu, et al.. (2024). Achieving deep intratumoral penetration and multimodal combined therapy for tumor through algal photosynthesis. Journal of Nanobiotechnology. 22(1). 227–227. 10 indexed citations
6.
Liu, Hui, Yanyan Wang, Xin Liu, et al.. (2023). Discovery of the First Subnanomolar PPARα/δ Dual Agonist for the Treatment of Cholestatic Liver Diseases. Journal of Medicinal Chemistry. 66(11). 7331–7354. 9 indexed citations
7.
Dai, Liang, et al.. (2022). Discovery of novel AdipoRon analogues as potent anti-inflammatory agents against nonalcoholic steatohepatitis. European Journal of Medicinal Chemistry. 244. 114800–114800. 9 indexed citations
8.
Liu, Hui, Jiaxin Li, Junlong Liu, et al.. (2022). Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis. Journal of Medicinal Chemistry. 65(3). 2571–2592. 26 indexed citations
9.
10.
Wang, Jin‐Zheng, Shengjie Liu, Xinyu Zhou, et al.. (2021). Discovery of Novel Small Molecule Inhibitors Disrupting the PCSK9-LDLR Interaction. Journal of Chemical Information and Modeling. 61(10). 5269–5279. 16 indexed citations
11.
Liu, Liu, Haobin Li, Kaiwen Hu, et al.. (2020). Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid. European Journal of Medicinal Chemistry. 209. 112932–112932. 37 indexed citations
12.
Shen, Tianyu, Zheng Zhang, Jianpeng Yu, et al.. (2019). KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells. Disease Markers. 2019. 1–9. 49 indexed citations
13.
Zhao, Wensi, Wanpu Yan, Dongbo Chen, et al.. (2019). Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.. PubMed Central. 9(6). 1183–1200. 24 indexed citations
14.
Shi, Qi, Luyan Shen, Bin Dong, et al.. (2018). Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy. Thoracic Cancer. 9(7). 836–846. 17 indexed citations
15.
Cheng, Chung Wah, Li Zhang, Chen Zhao, et al.. (2018). Whether Syndrome Differentiation Affects Treatment Result: Study Protocol of MaZiRenWan (麻子仁丸) for Functional Constipation in A Randomized Controlled Trial. Chinese Journal of Integrative Medicine. 25(3). 175–181. 3 indexed citations
16.
17.
Wu, Yuqing, Qi Sun, & Liang Dai. (2017). Immune regulation of miR-30 on the Mycobacterium tuberculosis-induced TLR/MyD88 signaling pathway in THP-1 cells. Experimental and Therapeutic Medicine. 14(4). 3299–3303. 31 indexed citations
18.
Zhong, Linda L. D., et al.. (2017). Evaluation of the Pharmacokinetics and Renal Excretion of Ma-Zi-Ren-Wan in Health Subjects. World Journal of Traditional Chinese Medicine. 3(2). 8–15. 2 indexed citations
19.
20.
Dai, Liang, et al.. (2012). TAK1, more than just innate immunity. IUBMB Life. 64(10). 825–834. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qianqian Yin Breakdown of academic impact, for papers by Mohammad Sarwar Jamal Breakdown of academic impact, for papers by Zhu Yuan Breakdown of academic impact, for papers by Yanli Jin Breakdown of academic impact, for papers by Xiaohui Hu Breakdown of academic impact, for papers by Wenhua Lu Breakdown of academic impact, for papers by Clarissa Araújo Gurgel Rocha Breakdown of academic impact, for papers by Chunlai Nie Breakdown of academic impact, for papers by Jie Jiang
Rankless by CCL
2026